PMID- 30529576
OWN - NLM
STAT- MEDLINE
DCOM- 20190212
LR  - 20190215
IS  - 1872-8227 (Electronic)
IS  - 0168-8227 (Linking)
VI  - 147
DP  - 2019 Jan
TI  - A systematic review on costs and cost-effectiveness of screening and prevention 
      of type 2 diabetes in women with prior gestational diabetes: Exploring uncharted 
      territory.
PG  - 138-148
LID - S0168-8227(18)31026-X [pii]
LID - 10.1016/j.diabres.2018.11.012 [doi]
AB  - AIMS: Women with gestational diabetes mellitus (GDM) are more likely to develop 
      type 2 diabetes mellitus (T2DM) as compared to women with normoglycemic 
      pregnancies. This study aims to explore the literature on cost(-effectiveness) of 
      screening and prevention of T2DM in women with prior GDM. METHODS: Five databases 
      were systematically searched, inclusion criteria were: (1) women with (prior) 
      GDM; (2) post-partum screening or prevention of T2DM; and (3) health-economic 
      evaluations. No year limits were applied. English, Dutch, French or German 
      publications were included. Quality was assessed using the Consensus Health 
      Economic Criteria checklist. RESULTS: Two cost-effectiveness analyses and two 
      cost analyses were found. One study evaluated nine screening strategies. Three 
      studies evaluated one prevention strategy each: intensive diet and behavioural 
      modification; annual counseling; and an annual dietary consultation. 
      Methodological quality was poor. Perspectives were unclear, time horizons were 
      too short, and no incremental analyses were performed. CONCLUSION: An oral 
      glucose tolerance test per three years leads to the lowest cost per case 
      detected, and prevention is potentially cost-effective or cost-saving. More 
      health economic evaluations are needed that compare all relevant alternatives, 
      including 'doing nothing'.
CI  - Copyright (c) 2018 Elsevier B.V. All rights reserved.
FAU - Werbrouck, Amber
AU  - Werbrouck A
AD  - Department of Public Health and Primary Care, Interuniversity Centre for Health 
      Economics Research (I-CHER), Ghent University, De Pintelaan 185, 9000 Gent, 
      Belgium; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 
      O&N2 bus 521, Herestraat 49, 3000 Leuven, Belgium. Electronic address: 
      amber.werbrouck@ugent.be.
FAU - Schmidt, Masja
AU  - Schmidt M
AD  - Department of Public Health, Interuniversity Centre for Health Economics Research 
      (I-CHER), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussel, Belgium.
FAU - Putman, Koen
AU  - Putman K
AD  - Department of Public Health, Interuniversity Centre for Health Economics Research 
      (I-CHER), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussel, Belgium.
FAU - Benhalima, Katrien
AU  - Benhalima K
AD  - Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, 
      Herestraat 49, 3000 Leuven, Belgium.
FAU - Verhaeghe, Nick
AU  - Verhaeghe N
AD  - Department of Public Health and Primary Care, Interuniversity Centre for Health 
      Economics Research (I-CHER), Ghent University, De Pintelaan 185, 9000 Gent, 
      Belgium; Department of Public Health, Interuniversity Centre for Health Economics 
      Research (I-CHER), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussel, 
      Belgium.
FAU - Annemans, Lieven
AU  - Annemans L
AD  - Department of Public Health and Primary Care, Interuniversity Centre for Health 
      Economics Research (I-CHER), Ghent University, De Pintelaan 185, 9000 Gent, 
      Belgium.
FAU - Simoens, Steven
AU  - Simoens S
AD  - Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, O&N2 bus 
      521, Herestraat 49, 3000 Leuven, Belgium.
LA  - eng
PT  - Journal Article
PT  - Systematic Review
DEP - 20181207
PL  - Ireland
TA  - Diabetes Res Clin Pract
JT  - Diabetes research and clinical practice
JID - 8508335
SB  - IM
MH  - Cost-Benefit Analysis/*methods
MH  - Diabetes Mellitus, Type 2/pathology/*prevention & control
MH  - Diabetes, Gestational/*economics/*prevention & control
MH  - Female
MH  - Humans
MH  - Mass Screening
MH  - Pregnancy
OTO - NOTNLM
OT  - Gestational diabetes mellitus
OT  - Health economics
OT  - Prevention
OT  - Systematic review
OT  - Type 2 diabetes mellitus
EDAT- 2018/12/12 06:00
MHDA- 2019/02/13 06:00
CRDT- 2018/12/12 06:00
PHST- 2018/07/05 00:00 [received]
PHST- 2018/09/27 00:00 [revised]
PHST- 2018/11/21 00:00 [accepted]
PHST- 2018/12/12 06:00 [pubmed]
PHST- 2019/02/13 06:00 [medline]
PHST- 2018/12/12 06:00 [entrez]
AID - S0168-8227(18)31026-X [pii]
AID - 10.1016/j.diabres.2018.11.012 [doi]
PST - ppublish
SO  - Diabetes Res Clin Pract. 2019 Jan;147:138-148. doi: 
      10.1016/j.diabres.2018.11.012. Epub 2018 Dec 7.